{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:12:04Z","timestamp":1761491524696,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmcl.2023.129165","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:58:50Z","timestamp":1675133930000},"page":"129165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and evaluation of heterocyclic 2-phenylacetate derivatives as water-soluble rapid recovery hypnotics"],"prefix":"10.1016","volume":"82","author":[{"given":"Jin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengkang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaonan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guisen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129165_b0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/bja\/42.3.249","article-title":"Propanidid","volume":"42","author":"Conway","year":"1970","journal-title":"Br J Anaesthesia"},{"key":"10.1016\/j.bmcl.2023.129165_b0010","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1080\/07391102.2017.1403959","article-title":"Possible binding sites and interactions of propanidid and AZD3043 within the \u03b3-aminobutyric acid type A receptor (GABA(A)R)","volume":"36","author":"Wang","year":"2018","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2023.129165_b0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2044.1984.tb07318.x","article-title":"Immune reaction to propanidid","volume":"39","author":"Christmas","year":"1984","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bmcl.2023.129165_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00003495-198122010-00002","article-title":"Adverse effects of intravenously administered drugs used in anaesthetic practice","volume":"22","author":"Clarke","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.bmcl.2023.129165_b0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/bja\/51.9.819","article-title":"An animal model for the investigation of adverse response to i.v. anaesthetic agents and their solvents","volume":"51","author":"Glen","year":"1979","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bmcl.2023.129165_b0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5009\/gnl20243","article-title":"Pain intensity at injection site during esophagogastroduodenoscopy using long- and medium-chain versus long-chain triglyceride propofol: a randomized controlled double-blind study","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver."},{"key":"10.1016\/j.bmcl.2023.129165_b0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archpedi.1981.02130310034012","article-title":"The fat overload syndrome: report of a case and literature review","volume":"135","author":"Heyman","year":"1981","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bmcl.2023.129165_b0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199507203330303","article-title":"Postoperative infections traced to contamination of an intravenous anesthetic, propofol","volume":"333","author":"Bennett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2023.129165_b0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1213\/ANE.0000000000000831","article-title":"First human study of the investigational sedative and anesthetic drug AZD3043: a dose-escalation trial to assess the safety, pharmacokinetics, and efficacy of a 30-minute infusion in healthy male volunteers","volume":"121","author":"Kalman","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bmcl.2023.129165_b0050","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/ALN.0b013e31825685a6","article-title":"AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis","volume":"116","author":"Egan","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bmcl.2023.129165_b0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmcl.2023.129165_b0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/LRA.S230728","article-title":"Delayed emergence from anesthesia: what we know and how we act","volume":"13","author":"Cascella","year":"2020","journal-title":"Local Reg Anesth."},{"key":"10.1016\/j.bmcl.2023.129165_b0065","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/ALN.0b013e31826d3bef","article-title":"Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action","volume":"117","author":"Husain","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bmcl.2023.129165_b0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/ALN.0b013e31826d3de2","article-title":"Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs","volume":"117","author":"Ge","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bmcl.2023.129165_b0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejmech.2014.10.073","article-title":"Phenyl acetate derivatives, fluorine-substituted on the phenyl group, as rapid recovery hypnotic agents with reflex depression","volume":"89","author":"Zhang","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129165_b0080","doi-asserted-by":"crossref","first-page":"e96518","DOI":"10.1371\/journal.pone.0096518","article-title":"Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative\/hypnotic agents","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2023.129165_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128497","article-title":"Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents","volume":"57","author":"Qi","year":"2022","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:21Z","timestamp":1760773581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":17,"alternative-id":["S0960894X23000434"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129165","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of heterocyclic 2-phenylacetate derivatives as water-soluble rapid recovery hypnotics","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129165"}}